Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
26.63
+1.11 (4.35%)
Mar 6, 2026, 1:33 PM EST - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.64 billion as of March 6, 2026. Its market cap has decreased by -2.53% in one year.
Market Cap
2.64B
Enterprise Value
1.52B
1-Year Change
-2.53%
Ranking
Category
Stock Price
$26.63
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.64B, an increase of 706.37%. That is a compound annual growth rate of 40.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.78B |
| Vera Therapeutics | 2.77B |
| Dianthus Therapeutics | 2.66B |
| Apellis Pharmaceuticals | 2.58B |
| Travere Therapeutics | 2.52B |
| Dyne Therapeutics | 2.51B |
| Wave Life Sciences | 2.48B |
| Adaptive Biotechnologies | 2.45B |